Morning Routine Spiced Up with Cyclodextrins Inspired by the Viral Trend
Move over cold plunges and celery juice — there’s a new viral morning trend sweeping through TikTok and Instagram reels.
Author: István Puskás
research chemist
FDA Grants Approval to HPBCD-Enhanced Biologic: A ‘Super-Originator’ Formulation
Cyclodextrin-based super-generics represent enhanced versions of reformulated drug products, offering improved performance and patient outcomes usually developed/marketed by a generic
Rapid test for identification of heptakis (2,6-di-O-methyl) β-cyclodextrin in isomeric mixtures
A rapid test was worked out to identify single isomer heptakis(2,6-di-O-methyl) β-cyclodextrin (2,6-DIMEB), an isomer with distinct methylation pattern compared
45 years of paracetamol (acetaminophen)–beta-cyclodextrin complex history – now used in versatile pharmaceuticals
According to the Cyclodextrin News Library Database, the first description of the paracetamol (acetaminophen)–beta-cyclodextrin complex, published in 1980, is partly
Cyclodextrin science helps dishes sparkle
In the realm of household cleaning, cyclodextrins play a pivotal role in enhancing the efficacy and environmental friendliness of products:
Use of odor-absorbing component, Hydroxypropyl-β-cyclodextrin in a new Japanese personal care product
Lion Corporation has announced novel antiperspirant products that are set to launch nationwide in Japan on April 4, 2025. Product
Cantrixil’s Career Shift: Orphan Drug Encapsulated in Alpha-Cyclodextrin Changes Hands (and Cyclodextrin)
On 31 March, 2025, Kazia Therapeutics (Australia) Announced sale of intellectual property and trademarks rights for Cantrixil, a product that
Meow! In Japan cyclodextrins are taking cat products to the next level! 😺
Aside from its packaging design, “Phytocare α-CD 150g” does not specifically appear to be a cat-focused product. However, the inclusion
Lessons from space studies on stability of a drug / cyclodextrin composition
Assessing the stability of drugs in space is crucial for future missions due to various environmental factors such as radiation,
FDA grants approval to Axsome Therapeutics’ migraine medication containing Betadex Sulfobutylether Sodium
The U.S. Food and Drug Administration has approved Axsome Therapeutics’ new migraine treatment tablet on 30 January 2025 [1]. Marketed